RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Radius Health Stock

Radius Health Revenue 2024

Radius Health Revenue

2.71 B USD

Ticker

RDUS

ISIN

US7504692077

WKN

A114VH

In 2024, Radius Health's sales reached 2.71 B USD, a -5.97% difference from the 2.88 B USD sales recorded in the previous year.

The Radius Health Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2026e2.8710,72
2025e2.8110,97
2024e2.7111,35
20232.8810,68
20223.4914,00
20212.7616,43
20201.7112,18
20192.1312,86
20182.3614,98
20171.6913,22
20161.3513,06
20151.929,02
20142.538,64
20132.627,92
20123.347,82
20113.4611,19
20102.312,23
20091.795,89
20083.5217,22
20072.5715,25
20061.8517,67
20050.8527,14
20040.6922,65

Radius Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Radius Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Radius Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Radius Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Radius Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Radius Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Radius Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Radius Health’s growth potential.

Radius Health Revenue, EBIT and net profit per share

DateRadius Health RevenueRadius Health EBITRadius Health Net Income
2026e2.87 B undefined0 undefined65.55 M undefined
2025e2.81 B undefined41.21 M undefined-18.69 M undefined
2024e2.71 B undefined-66.91 M undefined-138.62 M undefined
20232.88 B undefined31 M undefined-25.8 M undefined
20223.49 B undefined224.8 M undefined168.8 M undefined
20212.76 B undefined210.7 M undefined165.1 M undefined
20201.71 B undefined20.8 M undefined-4.1 M undefined
20192.13 B undefined82.8 M undefined56.3 M undefined
20182.36 B undefined145.3 M undefined156.5 M undefined
20171.69 B undefined51.5 M undefined44.5 M undefined
20161.35 B undefined27.7 M undefined-19.4 M undefined
20151.92 B undefined2.1 M undefined-197 M undefined
20142.53 B undefined31.5 M undefined5.9 M undefined
20132.62 B undefined17.6 M undefined-281.4 M undefined
20123.34 B undefined56.1 M undefined27.4 M undefined
20113.46 B undefined182.1 M undefined118.4 M undefined
20102.3 B undefined122.7 M undefined66.8 M undefined
20091.79 B undefined-58.1 M undefined-32.2 M undefined
20083.52 B undefined391.1 M undefined248.7 M undefined
20072.57 B undefined206.4 M undefined131.3 M undefined
20061.85 B undefined170.9 M undefined143.1 M undefined
2005853.1 M undefined173.5 M undefined146.9 M undefined
2004688.2 M undefined107.1 M undefined111.2 M undefined

Radius Health stock margins

The Radius Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Radius Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Radius Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Radius Health's sales revenue. A higher gross margin percentage indicates that the Radius Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Radius Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Radius Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Radius Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Radius Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Radius Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Radius Health Margin History

Radius Health Gross marginRadius Health Profit marginRadius Health EBIT marginRadius Health Profit margin
2026e10.68 %0 %2.28 %
2025e10.68 %1.47 %-0.67 %
2024e10.68 %-2.47 %-5.12 %
202310.68 %1.08 %-0.9 %
202214 %6.45 %4.84 %
202116.43 %7.64 %5.98 %
202012.18 %1.21 %-0.24 %
201912.86 %3.88 %2.64 %
201814.98 %6.14 %6.62 %
201713.22 %3.05 %2.64 %
201613.06 %2.05 %-1.43 %
20159.02 %0.11 %-10.29 %
20148.64 %1.24 %0.23 %
20137.92 %0.67 %-10.75 %
20127.82 %1.68 %0.82 %
201111.19 %5.26 %3.42 %
201012.23 %5.33 %2.9 %
20095.89 %-3.25 %-1.8 %
200817.22 %11.12 %7.07 %
200715.25 %8.02 %5.1 %
200617.67 %9.21 %7.72 %
200527.14 %20.34 %17.22 %
200422.65 %15.56 %16.16 %

Radius Health Aktienanalyse

What does Radius Health do?

Radius Health Inc. is an American pharmaceutical company specializing in the research, development, and marketing of products in the areas of osteoporosis, cancer therapy, and endocrinology. The company was founded in 2003 and is headquartered in Waltham, Massachusetts. The history of Radius Health Inc. began with the discovery of a new compound called Abaloparatide, which was intended for use in the treatment of osteoporosis. The company initiated a Phase III clinical trial to evaluate the efficacy and tolerability of the medication. In 2016, Abaloparatide was approved by the U.S. Food and Drug Administration (FDA) for the treatment of postmenopausal osteoporosis. Since then, Radius Health Inc. has evolved into a leading company specializing in improving women's health. The company has expanded its activities to include oncology and endocrinology and relies on innovative technologies and research to provide better treatment options and medications for patients. The business model of Radius Health Inc. is based on the development and marketing of cost-effective and effective products for the treatment of diseases. The company conducts extensive clinical research and strives to develop new drugs and therapies to improve the lives of women. Radius Health Inc. employs an open and agile corporate culture that promotes innovation and prioritizes the needs of patients. The products offered by Radius Health Inc. include a wide range of medications used in the treatment of osteoporosis, breast cancer, and other diseases. Abaloparatide, the company's flagship product, is a recombinant peptide agonist that stimulates bone formation and reduces the risk of fractures in postmenopausal women. Other products include Elacestrant, an investigative drug for the treatment of breast cancer, and RAD1901, a selective estrogen receptor modulator used in the treatment of hormone-dependent cancers. The company is also active in the field of digital health. Radius Health Inc. has developed an augmented reality app that assists doctors and patients in visualizing bone fractures and other conditions. The app is currently being tested in clinical trials and is expected to be widely used in the future. Overall, Radius Health Inc. is known for its innovative research activities and efforts to improve women's health. The company has an experienced and dedicated team of researchers, scientists, and executives working together to create better treatment options for patients. With a strong pipeline of products and a vision for the future of healthcare, Radius Health Inc. is on track to become a leading provider of medical products and services. Radius Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Radius Health's Sales Figures

The sales figures of Radius Health originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Radius Health’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Radius Health's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Radius Health’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Radius Health stock

How much revenue did Radius Health generate this year?

Radius Health has achieved a revenue of 2.71 B USD this year.

How much was the turnover of the company Radius Health compared to the previous year?

The revenue of Radius Health has increased by -5.97% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Radius Health?

The revenue of Radius Health is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Radius Health measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Radius Health so important for investors?

The revenue of Radius Health is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Radius Health pay?

Over the past 12 months, Radius Health paid a dividend of 0.75 USD . This corresponds to a dividend yield of about 4.05 %. For the coming 12 months, Radius Health is expected to pay a dividend of 0.86 USD.

What is the dividend yield of Radius Health?

The current dividend yield of Radius Health is 4.05 %.

When does Radius Health pay dividends?

Radius Health pays a quarterly dividend. This is distributed in the months of December, March, May, August.

How secure is the dividend of Radius Health?

Radius Health paid dividends every year for the past 1 years.

What is the dividend of Radius Health?

For the upcoming 12 months, dividends amounting to 0.86 USD are expected. This corresponds to a dividend yield of 4.64 %.

In which sector is Radius Health located?

Radius Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Radius Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Radius Health from 8/5/2024 amounting to 0.188 USD, you needed to have the stock in your portfolio before the ex-date on 7/22/2024.

When did Radius Health pay the last dividend?

The last dividend was paid out on 8/5/2024.

What was the dividend of Radius Health in the year 2023?

In the year 2023, Radius Health distributed 0.75 USD as dividends.

In which currency does Radius Health pay out the dividend?

The dividends of Radius Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Radius Health

Our stock analysis for Radius Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Radius Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.